Ophthalmic Drugs Market - Global Industry Analysis
Ophthalmic Drugs Market By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, and Others), By Drug Class (Antiallergy, Anti-VEGF Agents, Anti-inflammatory, Antiglaucoma, and Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, and Ointments), By Route Of Administration (Topical, Local Ocular, and Systemic), By Product Type (Prescription Drugs and OTC Drugs), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028
Published Date: 09-May-2022Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-3372
Status : Published
The global ophthalmic drugs market was valued at USD 38.13 billion in 2021 and is predicted to expand to USD 60.31 billion by 2028, with a CAGR of roughly 5.9%. The report looks at the ophthalmic drugs market's drivers, limitations, and difficulties, as well as their influence on demand during the projection period.